Market closed
Petros Pharmaceuticals Inc./$PTPI
Petros Pharmaceuticals shares are trading higher after the company announced improvements to its AI platform for enhancing SaaS-based Rx-to-OTC drug transitions.
5 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Petros Pharmaceuticals Inc.
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.
Ticker
$PTPI
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
18
ISIN
US71678J3086
Website
PTPI Metrics
BasicAdvanced
$268K
-
-$83.47
2.20
-
Price and volume
Market cap
$268K
Beta
2.2
52-week high
$0.33
52-week low
$0.12
Financial strength
Current ratio
0.405
Quick ratio
0.229
Long term debt to equity
-1.007
Total debt to equity
-98.911
Interest coverage (TTM)
-18.36%
Management effectiveness
Return on assets (TTM)
-28.97%
Return on equity (TTM)
-571.33%
Valuation
Price to revenue (TTM)
0.008
Price to book
-0.01
Price to free cash flow (TTM)
-0.015
Growth
Revenue change (TTM)
-12.20%
Earnings per share change (TTM)
-47.41%
3-year revenue growth (CAGR)
-13.18%
3-year earnings per share growth (CAGR)
-26.04%
PTPI News
AllArticlesVideos
Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform
Accesswire·3 days ago
Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches
Accesswire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Petros Pharmaceuticals Inc. stock?
Petros Pharmaceuticals Inc. (PTPI) has a market cap of $268K as of May 09, 2025.
What is the P/E ratio for Petros Pharmaceuticals Inc. stock?
The price to earnings (P/E) ratio for Petros Pharmaceuticals Inc. (PTPI) stock is 0 as of May 09, 2025.
Does Petros Pharmaceuticals Inc. stock pay dividends?
No, Petros Pharmaceuticals Inc. (PTPI) stock does not pay dividends to its shareholders as of May 09, 2025.
When is the next Petros Pharmaceuticals Inc. dividend payment date?
Petros Pharmaceuticals Inc. (PTPI) stock does not pay dividends to its shareholders.
What is the beta indicator for Petros Pharmaceuticals Inc.?
Petros Pharmaceuticals Inc. (PTPI) has a beta rating of 2.2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.